Maya in the Media

A collection of media featuring Maya and our team.

Download

Get our Press Kit

November 2, 2022

Seeking Psychedelics? Check the Data Privacy Clause

WIRED

Read more

September 1, 2022

Heroic Hearts Project and Maya Partner to Establish Advanced Data Capture Protocols for Veterans Seeking Psychedelic Treatments

Globe Newswire

Read more

May 16, 2022

Forget Burning Man — Psychedelic Shamans Now Heading to Davos

Bloomberg

Read more

May 5, 2022

Psychedelics Upstarts Are Beginning to Lay the Groundwork to Get Into Oregon

Business Insider

Read more

April 20, 2022

Building Business Resilience Through Commitment to the Team

Shifting Grounds Podcast, Keith Ferrazzi

Read more

April 15, 2022

Business of Psychedelics - Decentralizing Psychedelic Medicine

Stanford Podcasts

Read more

January 27, 2022

Psychedelic Medicine & Technology

Technology is helping clinicians achieve better outcomes with patients in so many different ways these days.

Read more

January 25, 2022

How Technology is Transforming Mental Health Assessment and Treatment

In 2020, Oregon voters approved a ballot measure to legalize a psychedelic substance, psilocybin.

Read more

January 12, 2022

Maya and National Psychedelics Association Announce Partnership to Support Psilocybin-Assisted Services in Oregon

Today, Maya (Maya PBC) and the National Psychedelics Association (NPA) announced their partnership.

Read more

December 22, 2021

Mydecine Signs LOI with Maya to Co-Develop a Novel Prescription Digital Therapeutic Platform Aiming to Further Increase Safety, Efficacy, and Accessibility of Psychedelic-Assisted Treatments

Mydecine Innovations Group announced today that the Company has signed an LOI with Maya.

Read more

December 17, 2021

Psychedelic Treatment Platform Maya Health Raises $4.3M, Bridging Clinical & Real-World Practices' Gap

Psychedelic treatments are on the cusp of being accepted therapies for the masses.

Read more

December 16, 2021

Psychedelic Diaries: David Champion

We talk with David Champion — CEO and Founder of Maya Health — about the discovery of intentional psychedelics.

Read more

September 27, 2021

Why Psychedelic Therapy Needs Best Practices & How to Get There

After years of depressive spells, Caroline wondered if psychedelics could create the shift she needed.

Read more

August 4, 2021

Episode: #10 In Cognito

David is the CEO and Co-Founder of Maya and a Director at Unlimited Sciences.

Read more

August 4, 2021

Here are the 15 hottest psychedelics startups that are set to take off in 2021, according to top investors

Business Insider

Read more

July 16, 2021

Top 5 Challenges Facing Psychedelic Practitioners Today

As the psychedelic renaissance continues, the need for qualified psychedelic practitioners grows.

Read more

June 25, 2021

Data: The Critical (Missing) Component to Psychedelic Therapy

Psychedelic therapy may be an uncommon practice, but it’s lightyears away from the fringe.

Read more

May 19, 2021

Psychedelic Spotlight Interviews David Champion

Maya Health's David Champion, discusses the importance of data and analytics in the growing psychedelics field.

Read more

May 4, 2021

Meet David Champion | Founder of Maya, a digital health platform for psychedelic therapists

We had the good fortune of connecting with David Champion and we’ve shared our conversation below.

Read more

October 19, 2020

Business Trip Podcast Featuring David Champion

On the Business Trip podcast, David Champion discusses how software can help psychedelic practitioners thrive.

Read more

October 19, 2020

Business Trip: David Champion

Today's episode features David Champion, CEO and co-founder of Maya.

Read more

October 12, 2020

Digital Solutions in Psychedelics: Thoughts From an Industry Leader

David Champion, CEO of Maya Health, has been a front-line player in this space from the level of grassroots organizer on

Read more

August 31, 2020

Prohibition Partners PSYCH 2020 Panel with David Champion

At Prohibition Partners LIVE, Maya's CEO David Champion spoke on the Importance of Data, Tech & Community in Psychedelics.

Read more